ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum

13 4 月, 2026

One Min Read

5 Views

原文: https://finance.yahoo.com/sectors/healthcare/articles/immunitybio-inc-ibrx-posts-strong-092944085.html

Last Update: 13 4 月, 2026

Written By

Other Articles

Previous

CleanSpark, Inc. (CLSK) Price Target Trimmed as Cantor Stays Bullish on AI Infrastructure

Next

Bitdeer Technologies Group (BTDR) Rating Lowered by Cantor Fitzgerald Amid Execution Concerns

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept